Pune, India, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The global recombinant proteins market size is estimated to flourish owing to the increasing research and development activities for developing advanced drugs to treat chronic diseases, observes Fortune Business Insights™ in an upcoming report, titled, “Recombinant Proteins Market Size, Share & Industry Analysis, By Type (Hormones, Growth Factors, Antibody, Enzyme, Others), By Application (Therapeutic, Research), By End User (Biopharmaceutical Companies, Academic & Research Institutes, Others) and Regional Forecast 2020-2027.” The demand for protein production systems is increasing rapidly amid the COVID-19 pandemic owing to its utilization in the testing process.
This report incorporates an in-depth analysis of the overall growth prospects in the market. Furthermore, it provides insights into the comprehensive competitive landscape of the global market. A dashboard overview of leading companies, including their marketing strategies, market contribution, and recent developments is presented in both historic and present contexts.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/recombinant-proteins-market-103492
Rising Instances of Chronic Diseases Worldwide to Drive Growth
The increasing prevalence of chronic diseases across the world is expected to drive the growth of the global recombinant proteins market. For instance, as per a report published by the World Health Organization on chronic diseases and health promotion, chronic diseases are likely to account for 60% of the global burden of diseases. In addition, the rising demand for protein biologics is set to further strengthen growth. However, the challenges associated with the regulatory approvals are projected to limit growth.
Increasing R&D in Pharmaceutical and Biotechnology Spaces to Aid North America Dominate
North America is estimated to lead the global recombinant proteins market due to the increasing research and development activities in pharmaceutical and biotechnology spaces. For instance, according to a research by Select USA, Over 800,000 people work in the biopharmaceutical industry in the U.S., including a broad range of occupations such as scientific research, technical support, and manufacturing.
At Fortune Business Insights, we are striving to help your business sustain amid the pandemic by offering a comprehensive report that includes a detailed impact analysis on the market.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/recombinant-proteins-market-103492
Investing in R&D to Help Key Players Develop Therapeutic Drugs
The global recombinant proteins market comprises various manufacturers and businesses focused on offering advanced solutions to gain a competitive edge. Prominent players are investing in R&D to identify new applications of recombinant proteins in order to develop therapeutic products for several diseases. This will help them expand their product portfolios.
Industry Developments-
- In June 2020, Lonza launched GSv9, a new media, to support the production of recombinant proteins using the company’s GS Gene expression system.
- In March 2020, AMS Biotechnology launched recombinant proteins and antibodies for the detection of the COVID-19 virus. The company offers a wide range of products including assays, recombinant proteins, and cell lines, particularly for drug development.
A List of Key Manufacturers Operating In the Global Recombinant Proteins Market Report:
- Sigma Aldrich Company Ltd.
- Novoprotein Scientific
- Thermo Fisher Scientific
- Merck KGaA
- Abcam PLC
- Lonza
- GenScript Biotech Corporation
- ProSpec Tany TechnoGene, Ltd.
- Others
Quick Buy - Recombinant Proteins Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103492
Global Recombinant Proteins Market Segmentation:
By Type
• Hormones
• Growth Factors
• Antibody
• Enzyme
• Others
By Application
• Therapeutic
• Research
By End User
• Biopharmaceutical Companies
• Academic & research Institutes
• Others
By Geography
• North America (USA, Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, the Rest of Latin America)
• Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/recombinant-proteins-market-103492
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
- Number of procedures and average price of procedures
- Replacement rate and pricing of capital equipment
- Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
- Market & technological trends, new product developments, product pipeline.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/recombinant-proteins-market-103492
Have a Look at Related Reports:
Botulinum Toxin Market Share and Global Trend By Application (Therapeutics, Aesthetics), By End User(Specialty & Dermatology Clinics, Hospitals & Clinics), By Type(Botulinum Toxin Type A, Botulinum Toxin Type B) and Geography Forecast till 2026
Next-Generation Sequencing (NGS) Market Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026
U.S. Biosimilars Market Share and Global Trend By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, Others), By Disease Indication (Cancer, Autoimmune Diseases, Others) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026
Rehabilitation Robots Market Share and Global Trend By Type (Therapeutic Robots, Exoskeleton Robots, Assistive Robots, Others), By End User (Rehabilitation Centers, Hospitals, Others) and Geography Forecast till 2026
Hemodialysis Equipment Market Share and Global Trend By Product (Hemodialysis Machines, Hemodialysis Consumables), By End User (Dialysis Centers & Hospitals, Home Healthcare) and Geography Forecast till 2025
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs